PRPF6

Chr 20AD

pre-mRNA processing factor 6

Also known as: ANT-1, ANT1, C20orf14, Prp6, RP60, SNRNP102, TOM, U5-102K

PRPF6 encodes a protein that functions as a component of the U4/U6-U5 tri-snRNP complex in the spliceosome, essential for pre-mRNA splicing, and also enhances steroid hormone receptor transactivation. Mutations cause autosomal dominant retinitis pigmentosa 60, a form of inherited retinal degeneration. The gene is highly constrained against loss-of-function variants (LOEUF 0.44), reflecting its essential role in RNA processing.

Summary from RefSeq, OMIM, UniProt
Research Assistant →

Primary Disease Associations & Inheritance

Retinitis pigmentosa 60MIM #613983
AD
0
Active trials
7
Pubs (1 yr)
3
P/LP submissions
0%
P/LP missense
0.44
LOEUF
Multiple*
Mechanism· predicted
Clinical SummaryPRPF6
Population Constraint (gnomAD)
Constrained for loss-of-function variants (OE-LoF 0.29) despite low pLI — interpret in context.
📋
ClinVar Variants
3 unique Pathogenic / Likely Pathogenic· 98 VUS of 200 total submissions
📖
GeneReview available — PRPF6
Authoritative clinical overview · Recommended first read
Open GeneReview ↗

Population Genetics & Constraint

gnomAD v4 — loss-of-function & missense intolerance

Missense constrained — critical functional residues
LoF Constraint
0.44LOEUF
pLI 0.003
Z-score 4.78
OE 0.29 (0.190.44)
Moderately constrained

More LoF-intolerant than ~75% of genes

Missense Constraint
4.85Z-score
OE missense 0.43 (0.380.47)
242 obs / 567.1 exp
Constrained

Highly missense-constrained (top ~0.1%)

Observed / Expected Ratios
LoF OE0.29 (0.190.44)
00.351.4
Missense OE0.43 (0.380.47)
00.61.4
Synonymous OE1.06
01.21.6
LoF obs/exp: 15 / 52.3Missense obs/exp: 242 / 567.1Syn Z: -0.75
Curated Mechanism (G2P)Gene2Phenotype (DDG2P) ↗
limitedPRPF6-related retinitis pigmentosaOTHERAD
DN
0.75top 25%
GOF
0.6833th %ile
LOF
0.3455th %ile

This gene has evidence for multiple mechanisms of pathogenicity (dominant-negative and gain-of-function). Both the Badonyi & Marsh prediction and the broader genomic evidence point to dominant-negative as the predominant mechanism. Different variants in this gene may act through different mechanisms — interpret in context of the specific variant.

DNprediction above median
GOFprediction above median

Note: In-silico variant effect predictors (SIFT, PolyPhen, REVEL, CADD) may underestimate pathogenicity of missense variants in genes with GOF or DN mechanisms. Consider functional evidence and clinical context.

Predictions from Badonyi M, Marsh JA. PLoS ONE. 2024;19(8):e0307312.

ClinVar Variant Classifications

200 submitted variants in ClinVar

Classification Summary

Pathogenic2
Likely Pathogenic1
VUS98
Likely Benign77
Benign3
Conflicting1
2
Pathogenic
1
Likely Pathogenic
98
VUS
77
Likely Benign
3
Benign
1
Conflicting

Curated Variants Distribution

Classified variants from ClinVar · 5 ACMG categories

ClassificationLoFMissense + InframeNon-codingSynonymousTotal
Pathogenic
0
0
2
0
2
Likely Pathogenic
0
0
1
0
1
VUS
6
83
8
1
98
Likely Benign
0
0
41
36
77
Benign
0
0
1
2
3
Conflicting
1
Total6835339182

LoF = frameshift, stop gained/lost, canonical splice · Counts from ClinVar esearch · Updated hourly

View in ClinVar →

Protein Context — Lollipop Plot

PRPF6 · protein map & ClinVar variants

Showing all ClinVar variants across the protein. Search a specific variant to highlight its position.

3D Protein StructureAlphaFold

Clinical Trials

Active and recruiting trials from ClinicalTrials.gov

No active trials found for this gene.

Search ClinicalTrials.gov →
Clinical Literature
Open Research Assistant →